Clinical Trial Update: Glutathione (GSH) In The Treatment of Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating glutathione (GSH) for the treatment of Parkinson's disease has completed, sponsored by the University of South Florida.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Glutathione (glutathione)

Snippet

Sponsor: University of South Florida | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED